Retatrutide 50mg
Triple GLP-1 / GIP / Glucagon receptor agonist
≥99.0%
Third-Party
COA
Also available in 10mg · 20mg · 30mg · 40mg — compare all sizes
Complete your research kit
Also searched as: Reta, R3ta, Reta peptide, LY3437943
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
Retatrutide 50mg is a lyophilised research peptide supplied for controlled laboratory and scientific investigation. Retatrutide is a single experimental peptide of interest because of its activity across three metabolically relevant receptor systems: the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon receptor (GCGR). The Retatrutide 50mg format provides researchers with a higher-quantity presentation for appropriately designed laboratory studies. This material is intended strictly for research use and is not supplied for human consumption or therapeutic use.
What Is Retatrutide 50mg?
Retatrutide is an investigational triple receptor agonist designed to interact with GLP-1, GIP and glucagon receptors. These receptors participate in interconnected metabolic and endocrine signalling pathways.
Its multi-receptor activity distinguishes retatrutide from compounds that primarily target a single incretin pathway. Researchers study this profile to investigate how simultaneous receptor activation may influence metabolic signalling and related biological processes under experimental conditions.
Key Research Areas
Retatrutide 50mg research is particularly relevant to metabolic and endocrine investigations. Areas of scientific interest include glucose-related signalling, energy homeostasis, lipid metabolism, receptor pharmacology and interactions between incretin and glucagon pathways.
Research has also examined how combined GLP-1R, GIPR and GCGR activity differs mechanistically from single- and dual-receptor approaches. Findings should be interpreted according to the specific experimental model and should not be assumed to represent established human outcomes.
Why Researchers Study Retatrutide
Retatrutide is scientifically interesting because one molecular structure can engage three distinct receptor pathways. GLP-1 and GIP receptors are associated with incretin signalling, while the glucagon receptor contributes to broader metabolic and energy-regulation pathways.
This triple-agonist architecture allows researchers to investigate receptor interactions and downstream signalling within one experimental framework. The 50mg presentation may also be useful where a larger quantity of research material is required for planned laboratory studies.
Retatrutide 50mg in Australia
Researchers looking for Retatrutide 50mg Australia should review the supplier’s current product listing for stock status, price, analytical documentation and domestic shipping information before ordering.
When comparing Retatrutide 50mg online, batch traceability and accessible analytical data are more meaningful research considerations than unsupported performance claims.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Retatrutide 50mg is supplied as a lyophilised research material. Researchers should consult the product’s batch documentation and Certificate of Analysis (CoA), where available, for verified information concerning identity, purity and analytical testing.
Analytical results such as HPLC or LC-MS data should only be quoted where confirmed for the specific batch. Laboratory purity does not establish clinical safety, efficacy or suitability for human use.
Storage & Handling
Storage and Laboratory Handling
Keep Retatrutide 50mg under the storage conditions specified in the accompanying product or batch documentation. Protect laboratory materials from inappropriate environmental exposure and handle them according to established laboratory procedures.
After reconstitution, researchers should follow validated laboratory protocols or batch-specific documentation. Unsupported stability periods, solvents or reconstitution concentrations should not be assumed.
Reconstitution calculator: Retatrutide 50mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
Retatrutide 50mg: Frequently Asked Questions
It is a 50mg presentation of the investigational triple GLP-1, GIP and glucagon receptor agonist retatrutide for laboratory research.
It is designed to activate GLP-1R, GIPR and GCGR, allowing researchers to examine multiple metabolic signalling pathways.
The term refers to its activity at three receptor systems: GLP-1, GIP and glucagon receptors.
Research areas include metabolic signalling, receptor pharmacology, glucose-related pathways, energy homeostasis and lipid metabolism.
Refer to the batch-specific analytical documentation for verified purity, identity and testing information.
CoA availability should be confirmed for the specific batch before purchase.
Follow the verified storage conditions supplied with the product or its batch documentation.
Check the supplier's current Australian listing for availability, price, batch documentation and domestic shipping details.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
Retatrutide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.